• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Scopus
  4. Defined Engineered Human Myocardium for Disease Modeling, Drug Screening, and Heart Repair
 
  • Details
  • Full
Options
2022
Book Article
Title

Defined Engineered Human Myocardium for Disease Modeling, Drug Screening, and Heart Repair

Abstract
Different engineered heart muscle formats have been developed for applications in disease modeling, drug screening, and heart repair. The advantage of 3D engineered versus 2D monolayer and 3D aggregate cardiomyocyte cultures is a clearly advanced degree of maturation, which in many aspects resembles the postnatal rather than the embryonic or fetal heart, in the most advanced 3D culture formats. According to the desired in vitro (disease modeling or drug screening) and in vivo (heart repair) application, scale and geometry of tissue engineered heart muscle must be adapted. In this updated methods paper, we report a simple and scalable (up and down) collagen-based protocol for the construction of Engineered Human Myocardium (EHM) under defined, serum-free conditions.
Author(s)
Tiburcy, M.
Universitätsmedizin Göttingen
Meyer, T.
Universitätsmedizin Göttingen
Satin, P.-L.
Universitätsmedizin Göttingen
Zimmermann, Wolfram-Hubertus
Institute of Pharmacology and Toxicology, University Medical Center Göttingen
Mainwork
Cardiac Tissue Engineering  
Open Access
DOI
10.1007/978-1-0716-2261-2_14
Additional link
Full text
Language
English
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Keyword(s)
  • Heart

  • Pluripotent stem cells

  • Tissue engineering

  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024